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Background: Declining childhood immunisation represents a serious public health problem globally, 
and in New Zealand. To guide efforts to increase immunisation coverage, this study monitors 
nationwide change in immunisation coverage since the introduction of the National Immunisation 
Register (NIR) in 2005 and spatiotemporal patterns of immunisation coverage from 2006 to 2017. 
 
Methods: The study population consisted of 4,482,499 individual immunisation records that were 
obtained from the NIR (2005–2017). Data on yearly and average immunisation coverage in census 
area units (CAUs) in New Zealand were calculated by milestone age (6/8/12/18/24/60/144 months). 
Data for 2005 were excluded due to missing records in the introductory period of the NIR. We analysed 
spatial and spatiotemporal patterns using Gi* and SaTScan methods.  
 
Results: Immunisation coverage improved since the introduction of the NIR in 2005, reaching a peak 
in 2014 and 2015 with a slight decrease in 2016 and 2017. Well and insufficiently immunised areas 
were identified with spatial autocorrelation analyses highlighting several hot- and cold-spots. 
Comparison of CAUs with neighbouring CAUs allowed for the identification of places where 
immunisation coverage was significantly higher or lower than expected, over both time and space. 
 
Conclusion: We provide the first spatiotemporal analysis of childhood immunisation in New Zealand 
that utilises a large sample of over 4.4 million individual immunisation records. Our spatial analyses 
enable policymakers to understand the development of childhood immunisation coverage and make 
more effective prevention strategies in New Zealand.  
 





Universal vaccination programmes that increase immunisation coverage have reduced the burden of 
infectious diseases in both developing and developed countries1 and the benefits of childhood 
vaccinations are now scientifically unquestioned2. However, while immunisation coverage has 
improved in many parts of the world, recent outbreaks serve to remind us just how these gains can 
be lost.3 Over the course of 2018, four of the six World Health Organization (WHO) regions had 
substantial measles outbreaks, and measles was once again endemic in every region of the world.3 
Declining immunisation coverage was said to be related to supply shortages and growing vaccine 
hesitancy.4 In another example, the United Kingdom (UK) has also seen a decrease in coverage of the 
measles-mumps-rubella vaccine to 91.2%, the fourth annual decline in a row and to its lowest level 
since 2011–12.5 Collectively, this evidence highlights the significant and urgent need for surveillance 
of immunisation coverage in developed countries such as New Zealand.  
 
Research on immunisation often focuses on attitudes towards immunisation6, surveillance and 
outbreaks events7,8 or uses survey-based methods9. Several pioneering global epidemiological studies 
have painted a picture of immunisation coverage with a broad brush; however, these studies often 
focus on developing countries and rarely depict detailed patterns that show within country or region 
variability which are important in developed countries such as New Zealand to inform research and 
policy.2,10,11 Indeed, several highly powered studies acknowledge that immunisation coverage is likely 
to show variability within the larger geographical areas that were analysed.10,12,13 Data at fine 
geographical scales and analyses that examine change over time are required to fully understand 
patterns of local immunisation coverage. Understanding where and why immunisation coverage may 
be declining over time and space is important as these areas can be at risk of losing their herd 
immunity.  
 
Emerging evidence utilising geospatial analyses have shown clusters of low immunisation coverage.14–
17 In one of the only spatiotemporal analyses investigating vaccine hesitancy, the largest increases 
were shown to have occurred in a relatively small proportion of regions throughout the state of 
California.11 Despite this emerging evidence, few studies to the authors knowledge have examined 
such spatiotemporal complexities using nationwide registry data.11 We extend evidence by using 
National Immunisation Register (NIR) data from 2006 to 2017 at a fine geographical scale (i.e. census 
area unit) in a sample of over 4.4 million childhood immunisation records from across New Zealand. 
This study investigates how immunisation coverage has developed in New Zealand since the 
introduction of the NIR in 2005. It then examines nationwide spatial and spatiotemporal trends and 





The New Zealand Ministry of Health provided the NIR for the years 2005–2017 at the meshblock 
geographical level (with identifiers of higher administrative units), including information about sex, 
prioritised ethnicity, milestone age in months, milestone year and milestone month, and census year. 
The full data consisted of 4,362,674 records representing an aggregation of 4,482,499 individual 
immunisation events. From those only events of fully immunised children were extracted (3,341,715 
records of 3,438,236 events). Data from 2005 was excluded from the analysis due to numerous missing 
records. All analyses were performed at the level of census area units (CAUs) geographies, based on 
the information about residency meshblock of the immunised children. CAUs are census 
administrative areas that, in urban areas, contain 3,000 to 5,000 people (2,004 CAUs in 2013). The 
birth data in CAUs were provided by Statistics New Zealand and included the number of live-born 
children in CAUs between 2005 and 2018. These counts were rounded to the base of three to ensure 
the confidentiality of individuals before providing the official data. 
2.2 Calculation of rates and trends of immunisation coverage 
development over time 
Counts of immunisation events and counts of live-born children were aggregated in CAUs. The 
immunisation rates for each milestone age (6/8/12/18/24/60/144 months) and year (2006–2017) 
were calculated as a percentage of fully immunised children and the total amount of children of 
applicable milestone age for each area. The month of immunisation and month of birth were 
considered to calculate the milestone age-specific immunisation since. 
2.3 Spatial and spatiotemporal trends and patterns in immunisation 
coverage  
The analysis of spatial and spatiotemporal autocorrelation enables the identification of areas that 
perform better or worse than their local neighbourhoods. This study investigated spatial and 
spatiotemporal trends and patterns of milestone age-specific immunisation coverage around New 
Zealand between 2006 and 2017. We used local Gi*18 to explore local spatial autocorrelation in the 
data. It is used as an indicator of local clustering that measures a concentration of spatial data19 
allowing for subsequent visualisation of the location of identified clusters18. The results distinguish 
between statistically significant clusters (p-value < 0.05) of high and low immunisation rates. We used 
the second-order queen’s contiguity scheme of the neighbourhood to obtain spatial weights for 
individual CAUs.20 GeoDA software package21 was used for the processing of the data and computing 
of the measures while QGIS 3.222 was used for geovisualisation of the clusters. 
 
Spatiotemporal scan statistics were then used to identify clusters of high and low rate areas 
simultaneously over space and time. This was processed using the open-source software SaTScan 
9.3.23 QGIS 3.2 was used for geovisualisation of clusters. Input data consisted of: (1) immunisation 
events aggregated into CAUs and grouped by year of the event; (2) demographic structure of CAUs 
represented by aggregated counts of births in CAUs; and (3) coordinates of CAU centroids. The 
retrospective space-time analysis of high and low rate clusters was based on input data applying the 
Discrete Poisson model.24 SaTScan was set to find clusters within a dynamic circular window including 
up to 10% of the population, while the maximum time span of the cluster was set to 90% of the study 
period. These values were selected due to focusing on rather small areas appearing long-term in time 
while trying to eliminate areas with an early deployment of NIR. We adjusted for the time by non-
parametric stratified randomization to ensure the comparability of rates within various time periods.25 
Resulting indirectly standardised rates (expressed as the relative risk) for each identified geographic 
cluster were estimated, and only significant clusters (p-value ≤ 0.001) remained in the results. The 
clusters consisting of only one CAU, as well as clusters appearing for a period of the first reliable year 
(2006 for 6/8/12-months milestone age, 2007 for 18/24-months milestone age and 2010 for 60-
months milestone age), were not considered due to the early introduction period of the NIR.  
3. Results 
3.1 Mapping of immunisation coverage and exploratory analysis using 
spatial autocorrelation 
Animated maps depicting the immunisation coverage for each milestone age can be found in the 
supplementary online materials (Supplementary Figure 1). In the years following the introductory 
period of the NIR (2005–2006), the overall immunisation coverage grew, more in the South Island than 
the North Island until reaching a peak in the years 2014 and 2015. A slight decrease in immunisation 
rates are visible since then. Immunisation rates are generally lower for milestone ages of 6, 8 and 18 
months than for “complete years” milestone ages of 12, 24 and 60 months. However, the 
immunisation rates at 8-months milestone age recorded the most rapid development in terms of 
improvement levelling the 12-months milestone age immunisation uptake during recent years. 
 
Figure 1 shows clusters of CAUs with an average immunisation coverage significantly different from 
their neighbourhood CAUs. Clusters of cold-spots of low immunisation coverage (purple shade) can 
be found within the major population centres of Auckland, Christchurch and Wellington regardless of 
the milestone age that is assessed. Cold-spots are the most notable for the immunisation coverage at 
6-months milestone age with large cold-spots identifiable in Northland and through the central North 
Island. This observation was also found for 18-months milestone age. The persisting cold-spots are not 
age specific, except 6-months milestone age located in the north-west coast region. Most hot-spots 
(light green shade) are found in rural areas of the central South Island. Both hot- and cold-spots are 
generally smaller for 8/12/24/60-months milestone age immunisation coverage than for 6- and 18-
months milestone age. 
 
Figure 1 Hot- and cold-spots of average immunisation coverage by milestone age 
3.2 Spatiotemporal patterns 
The following set of geovisualisations (Figure 2) represent spatiotemporal clusters of CAUs. Resulting 
significant clusters (p-value ≤ 0.001) indicate higher (positive) or lower (negative) levels of 
immunisation coverage when compared to neighbouring CAUs. The geovisualisations within Figures 2 
locate the cluster on the map while Supplementary Tables 1–6 in the supplementary material provide 
information on the start and end years of individual clusters, number of CAUs included, number of 
expected immunisation events and observed immunisation events, and the type of the cluster. The 
colours of the column match the colours in the maps. 
  
Spatiotemporal clusters of CAUs with low immunisation coverage were generally identified in densely 
populated areas of big cities such as Auckland, Christchurch, and Wellington as well as in the central 
North Island. A high number of clusters identified by individual analyses of milestone age-specific 
immunisation coverage indicates considerable spatial variation in the case of immunisation at 6, 8 and 
18-months when compared to immunisation coverage at 12, 24 and 60-months (Figure 2, 
Supplementary Figure 2 shows animated full resolution maps). Clusters of low immunisation coverage 
were not found elsewhere in the South Island other than in Christchurch urban area regardless of the 
milestone age. All maps and tables showing and describing spatiotemporal clusters are located in the 
supplementary online material.  
 
Figure 2 Geovisualisation of spatiotemporal clusters of immunisation coverage in New Zealand 
 
Main urban centres of Auckland, Christchurch and Wellington 
Many of the spatiotemporal clusters, of both low and high immunised areas, appeared in Auckland 
and Counties Manukau. However, most of these clusters are historical since they had lasted for a 
certain time and ended earlier than 2017 (Supplementary Tables 1-6). This means local differences of 
immunisation coverage in the area slowly disappeared. The split between the eastern coast (higher 
immunisation rates) and western coast (lower immunisation rates) is evident around Auckland in the 
case of 6, 8 and 18-months immunisation coverage. Only two historical clusters of low immunisation 
coverage were identified at 12 and 24-months milestone age. However, three persisting bigger 
clusters emerged on the west coast when looking at 60-months milestone age. 
 
No clusters were detected in Wellington for immunisation coverage at 12-months and 60-months 
milestone age. However, a temporary cluster (2006/2007–15) of low immunisation covering in the 
central city appeared for the remaining milestone ages of 6/8/18 months. Cluster 14 was classified as 
persisting in case of immunisation coverage at 24-month milestone age (Figure 2, Supplementary 
Table 5). A similar situation was found in Christchurch with differences being a pair of clusters instead 
of a single cluster. All clusters in Christchurch were temporary. The clusters of high immunisation rates 
were regularly detected in semi-rural areas south of Christchurch. 
 
Other areas 
A large persisting cluster of low immunisation coverage at 6-months milestone age was located in 
Northland. However, no clusters were identified for other milestone ages. The central North Island 
seems to be the region where clusters of low immunisation coverage were detected most often, they 
were also the largest ones. Although most of the clusters (regardless of the milestone age) lasted only 
for a limited time, the Bay of Plenty area seems to underperform in long-term immunisation coverage 
at 6, 18 and 60-months milestone age. The situation is analogous in the case of Lakes District Health 
Board in the central North Island where a persisting cluster of low immunisation coverage was 
identified for 6-, 24- and 60-months milestone age (Figure 2).  
 
Clusters were often identified in urban areas of Hamilton and Tauranga. Mostly clusters of high 
immunisation coverage persisting over time were detected in Tauranga for milestone ages of 18-, 24- 
and 60-months. The situation in Hamilton (and its vicinity) seems to be more complex. Both types of 
clusters assessed as persisting were located there. However, clusters of CAUs with low immunisation 
coverage generally appeared in the central urban area while high immunisation clusters were located 
in rather suburban areas around the outskirts. 
4. Discussion 
We provide the first nationwide spatiotemporal investigation of childhood immunisation in a large 
sample of over four million individual immunisation records from 2005 to 2017 across New Zealand at 
fine geographical scale. We respond to calls to monitor change in immunisation over time26 and extend 
knowledge by showing spatiotemporal changes in immunisation coverage. This study shows that since 
the introduction of the NIR in New Zealand, immunisation coverage has improved significantly 
reaching a peak in the years 2014 and 2015. However, a slight decrease in immunisation coverage is 
visible from 2015 to 2017. This study also demonstrates several areas of spatial autocorrelation. For 
example, several cold-spots where there are clusters of CAUs with lower immunisation coverage than 
in their neighbouring CAUs were identified in the major population centres of Auckland, Christchurch 
and Wellington regardless of the milestone age. Finally, this study contributes significantly to evidence 
by highlighting how spatial clusters of high and low immunisation change over time. We provide 
specific evidence for policy by highlighting the start and the end of individual clusters, number of CAUs 
included, and the number of expected immunisation events and observed immunisation events. 
 
Emerging evidence suggests that areas of low immunisation coverage cluster geographically.17,27,28 For 
instance, US evidence from California showed that of 50,233 children in the study population 
evaluated (2010 to 2012), 10,144 (21%) were identified as being within a cluster of low 
immunisation.17 Despite this, previous evidence is often restricted by smaller sample sizes,29 coarse 
geographic scales,26 limited geographical extents,30 limited temporal scope,31 and often by not 
simultaneously investigating both spatial and temporal complexity culminating in spatiotemporal 
trends. Our nationwide and spatiotemporal findings over a decade provide important evidence that 
help identify clusters of immunisation over time. Findings also help policymakers understand the 
development of childhood immunisation in New Zealand and help them to focus future efforts to 
increase vaccination coverage in specific geographical areas. This is important as previous evidence 
shows that low immunisation is associated with elevated risk of various outbreaks including measles 
and pertussis.32–34  
 
Child wellbeing and better population health outcomes, supported by a strong and equitable public 
health system, are key priorities for the New Zealand Ministry of Health in 2019/2035. In order to 
evaluate progress on these priorities, empirical evidence detailing each stage of childhood is needed. 
Thus, by considering temporal and spatial patterns at different stages of children’s lives, we are able 
to provide a comprehensive picture of child wellbeing and inform policy directed towards government 
priorities. Our findings assist both the Ministry of Health and regional district health boards in directing 
resources to either geographic areas or specific populations to improve health outcomes for children 
overall.  
 
Our retrospective analyses help to better understand national and regional evaluation of the efficacy 
of immunisation campaigns and outreach activities. Findings also enable improved area-specific 
understandings of policy and resource allocation. However, recent evidence suggests existing 
structural, economic, cultural and other factors are possible barriers to health care access36 and 
immunisation37. Hence, findings should be paired with information on the socioeconomic and 
demographic structure of clusters to identify not only places where it may be most appropriate to 
intervene, but also an appropriate intervention strategy (e.g. cultural). Locations of well-immunised 
child populations (hot-spots) indicate areas of good health outcomes for children. Consequently, such 
areas put less pressure on the health system due to healthier populations that are resilient to 
outbreaks of preventable diseases. 
 
Our findings should be interpreted in light of study limitations. While NIR data were obtained from 
2005–2017, the first years (2005 and 2006) were often not usable due missing data. This reflects a 
real-world scenario where the introduction of a reporting system such as the NIR needs time to be 
implemented. While data were harmonised to reflect the change of census geographies the milestone 
ages of immunisation schedules are not always round years. This means the number of children born 
in CAUs needed to be recalculated in order to comply with reporting of immunisation events in CAUs. 
For instance, children born in July or later are usually fully immunised during the following calendar 
year in the milestone age of 6 months. In addition to this, data used for the estimation of immunisation 
rates did not account for people’s mobility and therefore did not consider if a family moved to another 
CAU. When interpreting the results of the cluster analysis, it is necessary to realise that both methods, 
spatial and spatiotemporal scanning, provide estimates of local hot-spots and cold-spots. However, 
this does not have to be the case when compared to universal values such as a national target or 
national average.  
 
Moreover, this report analysed records of fully immunised children only. It also used rates computed 
for CAUs based on the NIR and live births provided by Statistics New Zealand. The estimates of 
immunisation rates in less populated CAUs may therefore be less precise due to the confidentiality of 
data. For instance, in the case of the birth registry, random rounding to the base of three protected 
the privacy in the data. Finally, the selection of suitable parameters is crucial for the spatiotemporal 
scan statistic. Combinations of other settings including spatial, temporal, and analytical parameters, 
were tested to evaluate the sensitivity of the method and results did not change considerably under 
any such parameter changes. Only larger and more populated clusters were identified as the result of 
aggregation. That means some of the local variations were hidden although the locations of primary 
clusters and their characteristics tend to be similar.  
5. Conclusion 
Our study used NIR data on over 4.4 million childhood immunisation events to examine nationwide 
spatiotemporal trends of immunisation coverage from 2006 to 2017. We identified areas of low 
immunisation coverage clustering across New Zealand. Although some of the identified clusters were 
only temporary, there are regions in New Zealand where low immunisation coverage is persistent 
which may indicate possible structural problems or inequities. Findings help policymakers to 
understand the development of childhood immunisation coverage in New Zealand and will inform 
effective future prevention strategies. In addition, an analysis of partial immunisations and vaccination 
hesitancy (both area-based and individual-based) could provide further insight. 
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Key points 
 National Immunisation Register was used to identify well and insufficiently immunised areas 
in New Zealand over time. 
 Some of the identified clusters were only temporary, however there are regions in New 
Zealand where low immunisation coverage is persistent which may indicate possible structural 
problems or inequities. 
 Findings help policymakers to understand the development of childhood immunisation 
coverage in New Zealand and will inform effective future prevention strategies. 
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Figure 1 Hot- and cold-spots of average immunisation coverage by milestone age 
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Supplementary Table 1 Properties of spatiotemporal clusters at 6-months milestone age 
ID Start End CAUs Observed Expected 
Cluster 
type 
1 2006 2012 60 16923 15018 High 
2 2006 2015 16 3375 4609 Low 
3 2008 2017 73 12662 14796 Low 
4 2006 2012 37 10257 8563 High 
5 2006 2014 3 1113 560 High 
6 2006 2015 6 2274 1461 High 
7 2006 2012 10 1145 1433 Low 
8 2006 2011 10 1593 940 High 
9 2006 2014 22 3177 2118 High 
10 2006 2017 99 21582 24797 Low 
11 2006 2015 65 36398 40431 Low 
12 2006 2017 152 27550 31028 Low 
13 2006 2017 7 1368 1006 High 
14 2006 2014 30 8832 11614 Low 
15 2006 2013 3 1161 834 High 
16 2006 2014 33 6760 8850 Low 
17 2006 2017 3 690 417 High 
18 2006 2017 8 3378 2256 High 
19 2007 2014 18 8853 10039 Low 
20 2006 2015 9 3411 4163 Low 
21 2006 2014 33 11973 8817 High 
22 2006 2011 172 15313 16766 Low 
23 2006 2014 48 13915 10940 High 
24 2006 2015 11 4104 1875 High 
25 2007 2016 69 15272 11398 High 
26 2006 2014 30 6536 9694 Low 
27 2007 2016 28 6242 5125 High 
28 2007 2016 88 38210 41066 Low 
29 2007 2016 81 17152 15482 High 
30 2006 2014 24 3304 4366 Low 
















Supplementary Table 2 Properties of spatiotemporal clusters at 8-months milestone age 
ID Start End CAUs Observed Expected 
Cluster 
type 
1 2006 2015 2 1584 1051 High 
2 2006 2017 2 1719 1078 High 
3 2006 2011 18 5193 4044 High 
4 2006 2015 3 1185 691 High 
5 2007 2014 65 35787 39777 Low 
6 2006 2014 3 1221 643 High 
7 2006 2008 10 1056 542 High 
8 2007 2016 99 50579 54824 Low 
9 2006 2015 6 2757 1739 High 
10 2007 2016 16 4054 5636 Low 
11 2006 2015 24 4269 5852 Low 
12 2006 2014 48 16229 13057 High 
13 2006 2014 30 11144 13885 Low 
14 2007 2014 69 14166 10488 High 
15 2006 2017 9 3243 3937 Low 
16 2006 2013 33 11976 9054 High 
17 2006 2015 53 14092 17752 Low 
18 2006 2015 11 4602 2184 High 
19 2006 2014 40 10325 14819 Low 
20 2006 2013 6 3126 2388 High 
21 2006 2011 117 11385 12910 Low 
22 2006 2011 71 8578 9899 Low 


























Supplementary Table 3 Properties of spatiotemporal clusters at 12-months milestone age 
ID 
 
Start End CAUs Observed Expected 
Cluster 
type 
1  2006 2012 6 2724 2049 High 
2  2007 2015 16 3729 5422 Low 
3  2006 2009 117 7274 8330 Low 
4  2006 2010 71 7424 8371 Low 
5  2006 2015 2 1626 1082 High 
6  2007 2013 20 5498 6619 Low 
7  2007 2015 11 4587 2141 High 
8  2006 2015 3 1251 712 High 
9  2007 2016 10 6087 7603 Low 
10  2006 2017 2 1737 1097 High 
11  2006 2015 6 2877 1811 High 












Supplementary Table 4 Properties of spatiotemporal clusters at 18-months milestone age 
ID Start End CAUs Observed Expected 
Cluster 
type 
1 2007 2009 29 1753 2050 Low 
2 2016 2016 10 56 110 Low 
3 2007 2012 3 426 790 Low 
4 2007 2015 5 2397 1757 High 
5 2007 2017 2 1623 1110 High 
6 2008 2016 28 6316 5219 High 
7 2007 2013 36 10851 9409 High 
8 2007 2014 6 3021 2277 High 
9 2008 2016 97 42396 45393 Low 
10 2007 2014 4 701 448 High 
11 2007 2017 9 4395 5155 Low 
12 2008 2016 9 2223 2825 Low 
13 2007 2017 8 3049 2465 High 
14 2007 2017 38 8045 9188 Low 
15 2007 2017 3 657 398 High 
16 2008 2016 25 4442 3642 High 
17 2007 2009 117 4843 5769 Low 
18 2007 2017 20 7374 9005 Low 
19 2008 2016 99 42322 46146 Low 
20 2007 2015 3 1149 630 High 
21 2008 2016 8 2631 1771 High 
22 2007 2015 24 3583 4940 Low 
23 2007 2013 27 8089 6810 High 
24 2007 2017 81 20743 18685 High 
25 2007 2015 26 5960 4832 High 
26 2007 2017 3 1233 731 High 
27 2007 2010 14 2052 1400 High 
28 2007 2017 2 1461 903 High 
29 2007 2015 53 11568 15035 Low 
30 2007 2017 16 3885 5691 Low 
31 2008 2016 69 14968 11317 High 
32 2007 2017 11 4884 2439 High 
33 2007 2015 40 9727 13977 Low 
34 2007 2017 6 2805 1824 High 
35 2007 2017 65 44941 49870 Low 
36 2008 2015 22 3375 2203 High 
37 2007 2017 30 13263 16280 Low 
38 2007 2015 15 7440 5489 High 
39 2007 2017 5 789 566 High 
40 2010 2017 3 389 242 High 
41 2007 2013 24 4181 3603 High 
42 2007 2014 6 441 665 Low 
43 2007 2014 3 972 1316 Low 
44 2008 2016 4 1176 872 High 
45 2007 2017 7 1393 1029 High 
46 2007 2015 7 969 690 High 
 
 
Supplementary Table 5 Properties of spatiotemporal clusters at 24-months milestone age 
ID Start End CAUs Observed Expected 
Cluster 
type 
1 2007 2015 6 3543 2771 High 
2 2008 2014 20 5473 6491 Low 
3 2008 2016 16 3417 5298 Low 
4 2007 2017 2 1713 1172 High 
5 2007 2012 3 414 851 Low 
6 2007 2017 2 1539 948 High 
7 2008 2016 11 4410 2091 High 
8 2007 2015 54 13727 19229 Low 
9 2007 2017 19 9732 11654 Low 
10 2007 2017 6 2976 1948 High 
11 2007 2017 3 1338 779 High 
12 2007 2017 9 3039 3600 Low 
13 2007 2010 78 6031 6786 Low 
14 2007 2017 24 4648 6550 Low 
15 2007 2017 12 2074 1591 High 








Supplementary Table 6 Properties of spatiotemporal clusters at 60-months milestone age 
ID Start End CAUs Observed Expected 
Cluster 
type 
1 2011 2017 223 39585 36111 High 
2 2010 2017 6 2088 1255 High 
3 2010 2017 3 957 438 High 
4 2010 2017 28 8930 11223 Low 
5 2010 2017 9 2403 2945 Low 
6 2014 2017 16 999 1286 Low 
7 2011 2017 259 39112 36984 High 
8 2011 2017 19 2719 2182 High 
9 2010 2017 2 1170 815 High 
10 2010 2017 2 1026 644 High 
11 2012 2017 3 486 359 High 
12 2013 2017 4 336 219 High 
13 2010 2017 3 59 133 Low 
14 2011 2017 29 5211 5817 Low 
15 2013 2017 20 2026 2383 Low 
16 2011 2017 103 32674 37666 Low 
17 2011 2017 99 32290 37573 Low 
18 2011 2017 63 26645 31969 Low 






Supplementary Figure 1 (Animated) Immunisation coverage in New Zealand (2006–2017) 
by year and milestone age 
https://1drv.ms/u/s!Akcs8gpB37mPgdd4IphlUFmFINWRzw?e=PDj7jL 
 
Supplementary Figure 2 (Animated) Geovisualisation of spatiotemporal clusters of 
immunisation coverage in New Zealand by milestone age 
https://1drv.ms/u/s!Akcs8gpB37mPgdd6F4T2NN2Ac1sLSA?e=5qIaF6 
 
 
 
